Latest stories on SUPN
Indivior Declares $8.13 Special Cash Dividend Contingent on Supernus Merger Closing
September 17, 2026
MarketChameleon54 · neutralm&a
Supernus Pharmaceuticals to Participate in September Investor Conferences
GlobeNewswire56 · neutralgeneral
Supernus Pharmaceuticals to Participate in September Investor Conferences
Business Insider56 · neutralgeneral
Supernus Pharmaceuticals, Inc. (SUPN) Indivior Pharmaceuticals, Inc., - M&A Call - Slideshow
Seeking Alpha50 · neutralm&a
Supernus and Indivior merge to create scaled, CNS-focused entity
Yahoo Top65 · bullishm&a
Why Supernus Pharmaceuticals Stock Topped the Market Today
The Motley Fool63 · neutralm&a
SUPERNUS PHARMACEUTICALS, INC. (SUPN) files 8-K
SEC 8-K50 · neutralgeneral
Supernus Pharmaceuticals, Inc. (SUPN) M&A Call Transcript
Seeking Alpha50 · neutralm&a
Supernus And Indivior Merger: There May Be Some Skepticism, But I Have Faith In This Deal
Seeking Alpha63 · neutralm&a
Are SUPN, ITGR, ATKR, LNTH Obtaining Fair Deals for their Shareholders?
Barchart50 · neutralgeneral
SUPN and Indivior to Merge: $2.2 Billion CNS Giant to Unlock $125 Million in Annual Cost Synergies
MarketChameleon67 · bullishm&a
Supernus Pharmaceuticals Q2 Earnings Call Highlights
Yahoo Top65 · bullishm&a
Indivior Q2 Earnings Call Highlights
Yahoo Finance65 · bullishm&a
Supernus and Indivior Announce Proposed Stock-for-Stock Merger
TipRanks63 · neutralm&a
Indivior and Supernus announce tax-free merger of equals
TipRanks55 · neutralm&a
Supernus Shares Jump After Revenue Beat, Higher Guidance and Indivior Merger Announcement
InvestorsHub73 · bullishm&a
Supernus Shares Jump After Revenue Beat, Higher Guidance and Indivior Merger Announcement
Yahoo Finance73 · bullishm&a
Indivior Delivers Record Q2 Results With 111% EBITDA Growth and Raises Full-Year Outlook
August 3, 2026
MarketChameleon76 · bullishearnings
Supernus jumps premarket on merger deal; GameStop drops
Investing.com Markets67 · bullishm&a
Supernus, Indivior merge to strengthen neuroscience drug portfolio
Reuters63 · neutralm&a
Supernus, Indivior stock jumps after all-stock deal to merge
Seeking Alpha65 · bullishm&a
Supernus and Indivior Announce All-Stock Merger of Equals
TipRanks65 · bullishm&a
Indivior Announces Merger Agreement to Acquire Supernus
TipRanks63 · neutralm&a
Why is Supernus Pharmaceuticals stock surging today?
Investing.com Markets50 · neutralgeneral
Supernus PharmaceuticalsEPS of -$1.01, revenue of $219.06M beats by $13.63M
Seeking Alpha67 · bullishearnings